CrystalO Biopharma

Shenzhen, China · Founded 2019 · Privately Held (backing)

Manufacturer of membrane protein drugs intended for neuropsychiatric disorders, chronic kidney disease and cardiovascular disease. CrystalO Biopharma is based in Shenzhen, China and was founded in 2019. It has raised $17.1 million.

Last price · $/share
—
Implied valuation
—
Total raised
$17.1M
Last round
—
Valuation — not yet established

No valuation for CrystalO Biopharma is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($17.1M) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of CrystalO Biopharma with a free account
  • ·Watch CrystalO Biopharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

CrystalO Biopharma funding history

No rounds on record

No funding rounds for CrystalO Biopharma are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

How CrystalO Biopharma's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For CrystalO Biopharma, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about CrystalO Biopharma

How much has CrystalO Biopharma raised?
CrystalO Biopharma has raised $17.1M in total funding across its recorded rounds.